UPDATE : Thursday, July 18, 2019
상단여백
Hanmi's short bowel syndrome treatment becomes orphan drug in US
The U.S. Food and Drug Administration has granted an orphan drug designatio...
by Lee Han-soo  |  2019-05-03 11:42
라인
Ministry OKs Lilly Korea’s metastatic breast cancer treatment
Lilly Korea has received sales approval from the Ministry of Food and Drug ...
by Lee Han-soo  |  2019-05-02 18:11
라인
GC marks sluggish sales in Q1
GC said Tuesday that sales by the company and its subsidiaries in the first...
by Lee Han-soo  |  2019-05-02 14:30
라인
Daewoong logs ₩238.1 billion sales in Q1
Daewoong Pharmaceutical recorded 238.1 billion won ($247.8 million) in sale...
by Lee Han-soo  |  2019-05-02 14:09
라인
‘MSD Korea’s monitoring program might be privacy breach’
MSD Korea’s “Self-Assurance” program, recording conversations of doctors at...
by Kim Yun-mi  |  2019-05-02 11:00
라인
Hanmi posts ₩274 billion in Q1 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 274.6 billion w...
by Lee Han-soo  |  2019-05-02 10:59
라인
HanAll unveils P2 trial results at ARVO 2019
HanAll Biopharma has presented the phase 2 clinical trial for HL036, a dry ...
by Lee Han-soo  |  2019-04-30 16:31
라인
Drugmakers brace for vaccine shortage amid surging hepatitis A cases
Pharmaceutical companies are closely monitoring the supply of hepatitis A v...
by Kim Yun-mi  |  2019-04-30 13:13
라인
Daewoong gets positive reviews of its BTX in EU
Daewoong Pharmaceutical said Friday that the European Medicines Agency'...
by Lee Han-soo  |  2019-04-29 16:13
라인
Yuyu releases research results for dry eye treatment in Canada
Yuyu Pharmaceutical has presented the results of a study for YDE, its pepti...
by Lee Han-soo  |  2019-04-29 14:33
라인
Corestem fails to get insurance benefit for Lou Gehrig’s drug
A state-run health insurance review agency has refused to grant insurance b...
by Song Soo-youn  |  2019-04-26 15:43
라인
Genexine, NeoImmuneTech apply combo treatment to breast cancer
Genexine, NeoImmuneTech have started administering its combination treatmen...
by Lee Han-soo  |  2019-04-26 12:00
라인
GC wins $35.7 million flu vaccine contract from Latin America
GC said Thursday it has secured a $35.7 million contract to supply influenz...
by Lee Han-soo  |  2019-04-25 17:52
라인
Hugel submits new drug application for BTX in China
Hugel has filed a new drug application (NDA) for Botulax, its botulinum tox...
by Lee Han-soo  |  2019-04-25 16:47
라인
FDA OKs AbbVie’s plaque psoriasis treatment
The U.S. Food and Drug Administration approved Skyrizi (Ingredient: risanki...
by Lee Han-soo  |  2019-04-25 15:53
라인
Korean units of Bayer, Fresenius sent largest dividends to parent firms
Among multinational pharmaceuticals’ offshoots operating in the nation, Bay...
by Lee Han-soo  |  2019-04-25 12:02
라인
‘PD-L1 expression poor marker for bladder cancer’s immunotherapy’
More than a year has passed since Tecentriq (atezolizumab), new immunothera...
by Kim Yun-mi  |  2019-04-25 11:52
라인
Daiichi Sankyo Korea to target anticancer market
Daiichi Sankyo Korea said it would expand its business in Kora to anticance...
by Lee Han-soo  |  2019-04-24 15:43
라인
Diarrhea drug Smecta banned for children under 2
The drug authorities have banned the use of dioctahedral smectite-containin...
by Lee Hye-seon  |  2019-04-24 15:42
라인
Medytox to start P3 trials for Medytoxin in treating overactive bladder
Medytox said Wednesday that it would begin Korea’s first phase 3 clinical t...
by Lee Han-soo  |  2019-04-24 14:06
여백
여백
여백
Back to Top